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We read with great interest the article by Gudra et al1 reporting a Faecal Immunochemical Test 
(FIT; OC-Sensor, Eiken Chemical) commonly used in colonic neoplasia screening as a reliable 
sampling device for microbiome profiling when compared with immediately frozen samples 
from whole stool. The potential to use the FIT routinely completed by approximately 3.5 
million participants annually as part of the English Bowel Cancer Screening Programme2 to 
understand the role of gut microbiome in colorectal neoplasia holds great promise, not least 
because of the convenience to individuals, cost-savings associated with use of routinely- 
collected samples, and methodological advantages of samples collected before microbiome-
altering procedures (e.g., bowel cleansing3). 
We aimed to validate and expand upon the finding of Gudra et al1 by investigating performance 
of the BCSP FIT, analysing more subjects, testing longer-term storage, investigating different 
methods of concentration, and comparing with OMNIgene.GUT (OG; DNAGenotek), a widely 
used research device for stool DNA preservation at ambient temperature4. We considered 
bacterial profile stability over time, mimicking real-world research scenarios with storage of 
FIT samples for up to 20 days prior to DNA extraction. We also explored whether concentration 
of samples by either speed vacuum (SV) or Lyophilisation (LY) is necessary to generate 
sufficient DNA yield from the FIT device. 
We collected faecal samples from 10 healthy volunteers. Samples were homogenised 
immediately, aliquoted and stored/processed according to 11 different test conditions (Table 
1), before extracting DNA on the corresponding day using the PowerSoil PowerLyzer DNA 
kit (QIAGEN). Faecal samples collected into a FIT tube adhered to the BCSPinstructions. 125 
samples including negative and positive controls underwent V4 16S rRNA gene sequencing. 
All samples were rarefied to 10,000 reads. 
Alpha-diversity (richness, FDR P=0.9; Shannon diversity, false discovery rate (FDR) P=0.44) 
was consistent within individuals regardless of test condition (Figure 1A and 1B). Beta-
diversity based on Bray-Curtis dissimilarity showed that samples grouped by patient 
(PERMANOVA P<0.001) and not test condition (PERMANOVA P=0.327) (Figure 1C), 
which was consistent with the presence/absence Jaccard index (patient PERMANOVA 
P<0.001; condition PERMANOVA P=0.99) (Figure 1D). EnvFit analysis further showed 
individual subject to be the only significant co-variate (P<0.001) (test condition (P=0.201); 
duration of storage (P=0.15)).   
While overall microbiota profiles were consistent within individuals, the relative abundance of 
eight genera (3% of 245 total genera) were significantly different between fresh, OG day 10, 
and FIT day 10 conditions. Blautia, Anaerostipes, Bifidobacterium, and Lachnospiracea were 
higher in FIT samples stored for 10 days at room temperature, with Parabacteroides, 
Bacteroides, and Sutterella lower (Kruskal-Wallis FDR P>0.05) (Figure 1E). Storage of FIT 
samples over 20 days resulted in no significant difference in alpha or beta-diversity, but 
Parabacteroides relative abundance reduced significantly between day 0 (mean 0.9% relative 
abundance) and day 20 (mean 0.2% relative abundance; FDR P=0.006). Storage at -80oC and 
concentrating samples by SV or LY had no effect on alpha-diversity, beta-diversity, or 
taxonomic profiles. 
In concordance with other studies exploring the potential of FITs for microbiome 
sequencing1,5–8, we found that faecal microbiome diversity and taxonomic profiles were 
consistent across test conditions. Notably, the changes in a small number (3%) of genera 
between fresh and FIT samples were consistent across all subjects. In addition, and contrary to 
the findings of Gudra et al1, we showed that combining bead-beating based DNA extraction 
with amplicon sequencing negated the need to concentrate samples prior to analysis, increasing 
the sample throughout. 
These important results demonstrate the potential of FIT, as obtained through a national 
screening programme, to provide a convenient, representative (i.e., sample obtained before 
bowel cleansing), and cost-effective means of studying faecal microbiota in a large population. 
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Table 1. Summary of the different test conditions that each faecal sample underwent 
Test 
condition 
label 
Test 
Days after 
defecation 
before 
extraction 
or storage 
Storage 
temperature 
Sample 
concentrator Description 
Fresh Day 0 Fresh faeces 0 RT NA Fresh sample  
FIT Day 0 FIT* 0 RT NA Sample added to FIT  
FIT Day 0 
SV FIT 0 RT Speed vacuum  
Sample added to FIT and speed vacuumed for 2 
hours 
FIT Day 0 
LY FIT 0 RT Lyophilisation  Sample added to FIT and lyophilised overnight 
OG Day 10 OMNIgene.GUT* 10 RT NA 
Sample added to OMNIgene.GUT and left at 
RT for 10 days 
FIT Day 10  FIT 10 RT NA Sample added to FIT and left at RT for 10 days 
FIT Day 10 
-80 FIT 10 
RT then -
80qC NA 
Sample added to FIT, left at RT for 10 days, 
then stored in -80qC for 1 month 
FIT Day 10 
-80 SV FIT 10 
RT then -
80qC Speed vacuum  
Sample added to FIT, left at RT for 10 days, 
stored in -80qC for 1 month, then speed 
vacuumed for 2 hours  
FIT Day 10 
-80 LY FIT 10 
RT then -
80qC Lyophilisation  
Sample added to FIT, left at RT for 10 days, 
stored in -80qC for 1 month, then lyophilised 
overnight 
-80 1M Fresh faeces 10 
RT then -
80qC NA 
Fresh sample stored at RT for 10 days then 
frozen at -80qC for 1 month 
FIT Day 20 FIT 20 RT NA Sample added to FIT and left at RT for 20 days 
FIT, faecal immunochemical tests; NA, nonapplicable; RT, room temperature. 
*use as per manufacturer’s instructions  
* *** * *
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Figure 1. Microbiota by subject and test condition. Panels A (subject) and B (test condition) 
display box plots for the alpha diversity by both richness (observed OTUs) and Shannon 
diversity, showing diversity is subject specific and not affected by the test condition. Displayed 
P values based on Kruskal-Wallis and adjusted using FDR. Samples. Panels C (subject) and D 
(test condition) display the beta diversity by both weighted Bray curtis and unweighted Jaccard 
indices. Ordination based on t-SNE. The faecal microbiota clusters by subject regardless of test 
condition. Panel E displays box plots comparing the relative abundance of bacterial genera 
from fresh day 0, FIT day 10, and OMNIgene GUT day 10. Genera are ordered by significance 
based on Kruskal-Wallis with FDR adjustment. Only the 10 most significantly different genera 
are shown. Red asterisk denote genera with a P value between 0.01 and 0.05. 
 
  
 
 
 
